Bioventus (BVS) Competitors

National Vision (NASDAQ:EYE) and Bioventus (NYSE:BVS) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Do analysts recommend EYE or BVS?

National Vision presently has a consensus price target of $24.18, suggesting a potential downside of 0.12%. Bioventus has a consensus price target of $13.75, suggesting a potential upside of 122.49%. Given Bioventus' stronger consensus rating and higher probable upside, analysts clearly believe Bioventus is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do institutionals & insiders hold more shares of EYE or BVS?

62.9% of Bioventus shares are held by institutional investors. 2.7% of National Vision shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has stronger valuation and earnings, EYE or BVS?

National Vision has higher revenue and earnings than Bioventus. National Vision is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.82B	1.05	-$28.50M	-$0.33	-73.36
Bioventus	$567.70M	0.89	-$156.23M	-$0.48	-12.88

Is EYE or BVS more profitable?

National Vision has a net margin of -1.40% compared to Bioventus' net margin of -7.11%. Bioventus' return on equity of 15.61% beat National Vision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	-1.40%	3.44%	1.40%
Bioventus	-7.11%	15.61%	4.01%

Does the media refer more to EYE or BVS?

In the previous week, National Vision had 10 more articles in the media than Bioventus. MarketBeat recorded 13 mentions for National Vision and 3 mentions for Bioventus. National Vision's average media sentiment score of 1.20 beat Bioventus' score of 0.70 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	5 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bioventus	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, EYE or BVS?

National Vision has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Summary

National Vision beats Bioventus on 9 of the 16 factors compared between the two stocks.